Granulosa Cell Mevalonate Pathway Abnormalities Contribute to Oocyte Meiotic Defects and Aneuploidy

Chuanming Liu,Wu Zuo,Guijun Yan,Shanshan Wang,Simin Sun,Shiyuan Li,Xinyi Tang,Yifan Li,Changjun Cai,Haiquan Wang,Wenwen Liu,Junshun Fang,Yang Zhang,Jidong Zhou,Xin Zhen,Tianxiang Feng,Yali Hu,Zhenbo Wang,Chaojun Li,Qian Bian,Haixiang Sun,Lijun Ding
DOI: https://doi.org/10.1038/s43587-023-00419-9
2022-01-01
Abstract:With aging, abnormalities during oocyte meiosis become more prevalent. However, the mechanisms of aging-related oocyte aneuploidy are not fully understood. Here we performed Hi-C and SMART-seq of oocytes from young and old mice and reveal decreases in chromosome condensation and disrupted meiosis-associated gene expression in metaphase I oocytes from aged mice. Further transcriptomic analysis showed that meiotic maturation in young oocytes was correlated with robust increases in mevalonate (MVA) pathway gene expression in oocyte-surrounding granulosa cells (GCs), which was largely downregulated in aged GCs. Inhibition of MVA metabolism in GCs by statins resulted in marked meiotic defects and aneuploidy in young cumulus-oocyte complexes. Correspondingly, supplementation with the MVA isoprenoid geranylgeraniol ameliorated oocyte meiotic defects and aneuploidy in aged mice. Mechanically, we showed that geranylgeraniol activated LHR/EGF signaling in aged GCs and enhanced the meiosis-associated gene expression in oocytes. Collectively, we demonstrate that the MVA pathway in GCs is a critical regulator of meiotic maturation and euploidy in oocytes, and age-associated MVA pathway abnormalities contribute to oocyte meiotic defects and aneuploidy.
What problem does this paper attempt to address?